Gene · 10818
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer. | Cancer Res | 2023 | 37934115 | PubTator, text mining | PubMed |
| Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment. | Biomedicines | 2023 | 37893023 | PubTator, text mining | PubMed |
| Case Report: Primary low-grade dedifferentiated liposarcoma of the urinary bladder with molecular confirmation. | Front Oncol | 2023 | 37881487 | PubTator, text mining | PubMed |
| Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity. | Open Biol | 2023 | 37875162 | PubTator, text mining | PubMed |
| A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma. | Mol Ther Nucleic Acids | 2023 | 37869260 | PubTator, text mining | PubMed |
| Adipose stem cells in tissue regeneration and repair: From bench to bedside. | Regen Ther | 2023 | 37854632 | PubTator, text mining | PubMed |
| Genomics of Treatable Traits in Asthma. | Genes (Basel) | 2023 | 37761964 | PubTator, text mining | PubMed |
| FGFR families: biological functions and therapeutic interventions in tumors. | MedComm (2020) | 2023 | 37750089 | PubTator, text mining | PubMed |
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. | Cell Death Dis | 2023 | 37749143 | PubTator, text mining | PubMed |
| LncRNA SNHG6 role in clinicopathological parameters in cancers. | Eur J Med Res | 2023 | 37735423 | PubTator, text mining | PubMed |
| Cardiac microRNAs: diagnostic and therapeutic potential. | Arch Med Sci | 2023 | 37732050 | PubTator, text mining | PubMed |
| Setting sail: Maneuvering SHP2 activity and its effects in cancer. | Adv Cancer Res | 2023 | 37704288 | PubTator, text mining | PubMed |
| IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. | Cancers (Basel) | 2023 | 37686528 | PubTator, text mining | PubMed |
| Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials. | Ann Oncol | 2023 | 37673211 | PubTator, text mining | PubMed |
| Whole exome sequencing of well-differentiated liposarcoma and dedifferentiated liposarcoma in older woman: a case report. | Front Med (Lausanne) | 2023 | 37649981 | PubTator, text mining | PubMed |
| Identifying Significantly Perturbed Subnetworks in Cancer Using Multiple Protein-Protein Interaction Networks. | Cancers (Basel) | 2023 | 37627118 | PubTator, text mining | PubMed |
| Opportunities and challenges of protein-based targeted protein degradation. | Chem Sci | 2023 | 37592990 | PubTator, text mining | PubMed |
| Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling. | Int J Mol Sci | 2023 | 37569547 | PubTator, text mining | PubMed |
| Metastasis-related long non-coding RNAs AL359220.1, SH3BP5-AS1 and ZF-AS1 are significant for prognostic assessment of lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37566767 | PubTator, text mining | PubMed |
| FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics. | Front Oncol | 2023 | 37546410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10818/papers?page=5